Header cover image

Swedish (OMX) Biotech Industry Analysis

UpdatedJul 12, 2024
DataAggregated Company Financials
Companies64
  • 7D1.9%
  • 3M8.9%
  • 1Y17.2%
  • YTD-3.1%

BioArctic is up 7.2%, leading the way for the Biotech industry, which has gained 1.9%. Meanwhile, Probi actually underperformed within the industry, shrinking 8.8% in the last week. This means that the industry has gained 17% over the past year. Looking forward, earnings are forecast to grow by 39% annually.

Industry Valuation and Performance

Has the Swedish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 13 Jul 2024SEK 196.5bSEK 30.6b-SEK 5,534,756,552.1339.1x-35.5x6.4x
Mon, 10 Jun 2024SEK 196.5bSEK 30.6b-SEK 5,437,393,166.6639.3x-36.1x6.4x
Wed, 08 May 2024SEK 187.3bSEK 31.0b-SEK 5,446,834,348.0050.2x-34.4x6.1x
Fri, 05 Apr 2024SEK 182.0bSEK 29.8b-SEK 5,279,260,269.2062.3x-34.5x6.1x
Sun, 03 Mar 2024SEK 179.3bSEK 29.8b-SEK 5,621,314,313.8151.9x-31.9x6x
Tue, 30 Jan 2024SEK 188.9bSEK 28.7b-SEK 1,193,664,009.0059.3x-158.3x6.6x
Thu, 28 Dec 2023SEK 184.0bSEK 28.7b-SEK 1,195,852,696.0061.3x-153.8x6.4x
Sat, 25 Nov 2023SEK 172.5bSEK 28.7b-SEK 1,176,413,333.0054.2x-146.7x6x
Mon, 23 Oct 2023SEK 150.7bSEK 27.4b-SEK 1,984,284,666.0048.1x-75.9x5.5x
Wed, 20 Sep 2023SEK 150.0bSEK 27.4b-SEK 1,977,779,638.0050.3x-75.9x5.5x
Fri, 18 Aug 2023SEK 154.3bSEK 27.6b-SEK 1,574,812,915.0053x-98x5.6x
Sun, 16 Jul 2023SEK 153.9bSEK 26.5b-SEK 1,385,021,170.0046.2x-111.1x5.8x
Tue, 13 Jun 2023SEK 174.8bSEK 26.4b-SEK 1,257,275,882.0045.8x-139x6.6x
Thu, 11 May 2023SEK 168.7bSEK 26.4b-SEK 1,360,505,273.0044.7x-124x6.4x
Sat, 08 Apr 2023SEK 171.3bSEK 25.4b-SEK 2,037,029,771.0038.4x-84.1x6.7x
Mon, 06 Mar 2023SEK 173.6bSEK 25.4b-SEK 2,030,738,794.0040.2x-85.5x6.8x
Wed, 01 Feb 2023SEK 173.2bSEK 23.8b-SEK 1,872,770,993.0042.5x-92.5x7.3x
Fri, 30 Dec 2022SEK 157.8bSEK 23.8b-SEK 1,842,501,005.0031.7x-85.6x6.6x
Sun, 27 Nov 2022SEK 162.0bSEK 23.8b-SEK 1,777,120,203.0031.1x-91.2x6.8x
Tue, 25 Oct 2022SEK 148.2bSEK 23.3b-SEK 3,159,299,885.0032.9x-46.9x6.4x
Thu, 22 Sep 2022SEK 142.5bSEK 22.9b-SEK 3,318,685,807.0033.6x-42.9x6.2x
Sat, 20 Aug 2022SEK 171.4bSEK 22.6b-SEK 3,543,450,488.0035.5x-48.4x7.6x
Mon, 18 Jul 2022SEK 164.4bSEK 21.9b-SEK 3,481,780,919.0043x-47.2x7.5x
Wed, 15 Jun 2022SEK 148.7bSEK 21.4b-SEK 3,527,739,017.0038.3x-42.2x6.9x
Fri, 13 May 2022SEK 143.4bSEK 21.4b-SEK 3,336,827,368.0044.2x-43x6.7x
Sun, 10 Apr 2022SEK 176.5bSEK 19.7b-SEK 3,199,792,054.0051.1x-55.1x9x
Tue, 08 Mar 2022SEK 147.4bSEK 19.6b-SEK 3,014,090,276.0047.3x-48.9x7.5x
Thu, 03 Feb 2022SEK 175.2bSEK 19.1b-SEK 2,251,173,837.0054.1x-77.8x9.2x
Sat, 01 Jan 2022SEK 200.6bSEK 19.1b-SEK 2,003,719,849.0053.3x-100.1x10.5x
Mon, 29 Nov 2021SEK 194.9bSEK 19.0b-SEK 1,980,721,534.0052.6x-98.4x10.2x
Wed, 27 Oct 2021SEK 202.0bSEK 18.9b-SEK 1,184,669,738.0054.4x-170.5x10.7x
Fri, 24 Sep 2021SEK 214.3bSEK 18.1b-SEK 1,339,248,248.0052.4x-160x11.8x
Sun, 22 Aug 2021SEK 190.4bSEK 18.1b-SEK 1,175,418,285.9555.4x-162x10.5x
Price to Earnings Ratio

-165.3x


Total Market Cap: SEK 194.3bTotal Earnings: -SEK 1,175,418,285.95Total Revenue: SEK 18.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Biotech Industry Price to Earnings3Y Average -86.5x202220232024
Current Industry PE
  • Investors are pessimistic on the Swedish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 7.3x is higher than the industry's current PS ratio of 6.4x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 19% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market0.81%
Healthcare2.75%
Biotech1.89%
Biotech1.89%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SOBI Swedish Orphan BiovitrumSEK 285.003.0%
+SEK 2.9b
40.1%PE45.2x
BIOA B BioArcticSEK 236.807.2%
+SEK 1.4b
-15.1%PS82.9x
VITR VitrolifeSEK 181.006.0%
+SEK 1.4b
3.5%PS7x
BONEX Bonesupport HoldingSEK 283.005.3%
+SEK 933.2m
101.4%PE64.4x
EGTX Egetis TherapeuticsSEK 5.4220.7%
+SEK 272.1m
37.9%PS25.2x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

BONEX

SEK 267.20

Bonesupport Holding

7D

-0.6%

1Y

90.2%

SOBI

SEK 279.40

Swedish Orphan Biovitrum

7D

1.0%

1Y

37.4%

EGTX

SEK 5.42

Egetis Therapeutics

7D

20.7%

1Y

37.9%

HNSA

SEK 51.15

Hansa Biopharma

7D

5.6%

1Y

22.3%

DMYD B

SEK 13.34

Diamyd Medical

7D

-5.4%

1Y

38.1%

PROB

SEK 271.00

Probi

7D

-8.8%

1Y

45.7%

BINV

SEK 36.60

BioInvent International

7D

12.6%

1Y

104.7%

CURAS

DKK 11.20

Curasight

7D

-7.1%

1Y

-44.0%

SANION

SEK 3.45

Saniona

7D

-6.0%

1Y

-54.7%

BIOA B

SEK 236.80

BioArctic

7D

7.2%

1Y

-15.1%

ABLI

SEK 0.23

Abliva

7D

41.1%

1Y

-1.1%

VITR

SEK 181.00

Vitrolife

7D

6.0%

1Y

3.5%